短肠综合征
Short bowel syndrome
定义
短肠综合征是一种由先天性缺陷、肠梗死或广泛手术切除引起的肠功能衰竭，其特征为腹泻、营养物质吸收不良、肠道扩张和运动障碍。
基本事实
- 患病率
- 1-9 / 100 000（Europe）
近两年的全球研究 1,746L2
2024/10 起在 Europe PMC 检索所得，按发表时间倒序显示最近 20 篇。标题未译成中文——自动翻译需要接入 LLM 服务，尚未引入。
- 2026-10Abstracts
- 2026-10开放获取A Post-NGP Mitsuokella jalaludinii as a Therapeutic Candidate for Gout
- 2026-09Characterization of Splanchnic Blood Flow in Patients with Chronic Intestinal Failure
- 2026-09开放获取Identification and validation of a robust inflammation-related three-gene signature for the diagnosis of neonatal necrotizing enterocolitis via machine learning integration
- 2026-09FEEDING CHALLENGES IN PEDIATRIC INTESTINAL FAILURE: INSIGHTS FROM THREE DIFFERENT INSTRUMENTS
- 2026-09开放获取Multicentre, prospective, observational study on the effectiveness and safety of upadacitinib for active perianal fistulising Crohn's disease in patients with prior anti-tumour necrosis factor failure: a study protocol
- 2026-09综述Small Intestinal Bacterial Overgrowth in the Pediatric Population: A Review of Pathophysiology, Diagnosis, and Management
- 2026-09综述开放获取Updates in the Management of Short Bowel Syndrome Secondary to Intestinal Resection in the Pediatric Population
- 2026-09综述开放获取Gut microbiota: a novel key player in urinary stone formation - from oxalate metabolism to systemic regulation
- 2026-09开放获取Urinary Hypaphorine as a Candidate Marker of FFQ-Derived Legume Intake Within the EAT-Lancet Framework in Free-Living Adults
- 2026-09Safety and long-term effectiveness of teduglutide in children with intestinal failure due to short bowel syndrome: a multicenter, post-marketing cohort study
- 2026-09综述开放获取Effectiveness, safety, and quality of life outcomes of teduglutide treatment in adult patients with short bowel syndrome-associated intestinal failure: A systematic literature review of real-world studies
- 2026-09开放获取The Association Between Vitamin D Status and Depression Severity in Adults with Major Depressive Disorder: A Cross-Sectional Study
- 2026-09病例报告开放获取A Rare Case of Neonatal-Onset Diarrhea Due to Congenital Tufting Enteropathy: Clinical, Histopathological, and Genetic Insights
- 2026-09荟萃分析系统综述综述开放获取Measurement of Fecal Energy Loss Using Bomb Calorimetry in Adult Patient Populations: A Systematic Review and Meta-Analysis
- 2026-09综述开放获取Glutamine and Pediatric Intestinal Barrier Function: A Scoping Review of Clinical Evidence and Research Gaps
- 2026-09综述开放获取Biological Insights into Intestinal Adaptation from Preclinical Models of Short Bowel Syndrome
- 2026-09Four Radical Bowel-Sparing Procedures for the Treatment of Small Bowel Tumors: A Retrospective Cohort Study From a Prospective Clinical Trial
- 2026-09开放获取[<sup>18</sup>F]AlF-FAPI-74 PET/CT for preoperative assessment of the peritoneal cancer index and comparison with MRI-based, surgical and pathological assessment in colorectal cancer patients eligible for CRS-HIPEC: study protocol for a prospective observational proof-of-concept study
- 2026-09系统综述Understanding the gut microbiota to shape the future of intestinal failure care: a systematic review of the evidence
境外已获批用于本病的药物 4L2
欧盟 1 项、美国 3 项。同一药物在两地各批一次的，会分别列出。
「境外已获批」不等于「在中国能用」。中间隔着进口注册、临床急需境外新药通道、海南博鳌乐城国际医疗旅游先行区等几条路径，各有各的条件与费用。这一节能确定地告诉你的只有一件事：这个病在世界范围内已经有获得批准的药物，它叫什么名字。拿这个名字去问主治医生，是下一步最省力的做法。
药名一律保留英文原文，不作翻译——中国的药品通用名与英文名的音译经常不一致，译错会让人去找一个不存在的药。
- Teduglutide Viatris欧盟2026-01-08teduglutide官方记录
- Zorbtive美国2003-12-01Somatropin (r-DNA)官方记录
- NutreStore美国2004-06-10Glutamine官方记录
- GATTEX美国2012-12-21teduglutide [rDNA origin]官方记录
尚未获批的在研药物（19 项）
这些药已被欧盟或美国的监管机构认定为罕见病用药（英文 orphan drug designation，中文行业里通称「孤儿药资格」——「孤儿」说的是这类药市场太小、没有厂商愿意认领，不是在说病人）。但这只是一种监管身份：意味着监管机构给予研发上的激励，不代表这个药已被证明有效，也不代表将来一定能上市，绝大多数最终不会成药。列在这里是为了看清有哪些方向正在被尝试。
- [Gly2]-recombinant human glucagon-like peptide欧盟2001-12-12Treatment of short bowel syndrome官方记录
- oxalobacter formigenes strain HC-1欧盟2014-10-15Treatment of short bowel syndrome官方记录
- insulin human欧盟2015-08-10Treatment of short bowel syndrome官方记录
- apraglutide欧盟2018-11-19Treatment of short bowel syndrome官方记录
- human glucagon-like peptide-2 analogue linked to a human immunoglobuli欧盟2019-01-11Treatment of short bowel syndrome官方记录
- crofelemer欧盟2021-12-10Treatment of short bowel syndrome官方记录
- Recombinant human insulin-like growth factor-I美国2000-02-16Treatment of short-bowel syndrome as a result of resection of the small bowel or as a result of congenital dysfunction of the intestines.官方记录
- conjugated bile acids美国2003-07-18Treatment of steatorrhea in patients with short bowel syndrome官方记录
- opium tincture美国2011-12-02Treatment of chronic diarrhea in short bowel syndrome patients with an inadequate response to anti-diarrheal treatment官方记录
- human insulin (rDNA)美国2015-04-06Treatment of short bowel syndrome (SBS).官方记录
- docosahexaenoic acid美国2015-06-01Treatment of short bowel syndrome官方记录
- recombinant fusion protein comprising exenatide and XTEN美国2015-10-07Treatment of short bowel syndrome.官方记录
- melatonin美国2017-02-14Treatment of short bowel syndrome官方记录
- crofelemer美国2017-08-02Treatment of short bowel syndrome官方记录
- glepaglutide美国2017-10-20Treatment of short bowel syndrome官方记录
- Glucagon-Like Peptide 2 fused to hyFc美国2018-10-11Treatment of short bowel syndrome官方记录
- apraglutide美国2018-12-20Treatment of short bowel syndrome (SBS)官方记录
- human glucagon-like peptide-2 analogue linked to a human immunoglobuli美国2019-05-01Treatment of short bowel syndrome官方记录
- Arginine butyrate美国2023-03-09Treatment of Short Bowel Syndrome官方记录
数据来自欧洲药品管理局（EMA）的药品与罕见病用药资格公开导出表，以及美国 FDA 的罕见病用药资格数据库（Orphan Drug Product Designation Database）。两边口径不同：欧盟一侧取的是当前状态仍为「已授权」的药品；美国一侧记录的是「曾获批准」这一事实，FDA 的公开表不追踪药物此后是否退市（例如 Relyvrio 于 2024 年撤市，表中仍记为已获批）。请以官方记录页为准。
在中国开展的临床试验 13L2
按病名在 ClinicalTrials.gov 检索、并校验研究中心含中国大陆而来。登记状态不等于现在真的能入组——务必按 NCT 号到原站核实，并与主治医生商量。
登记为可入组 4
- 招募中NCT07691125Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome中国研究中心 2 个：Nanjing、Xiamen
- 招募中NCT06512584Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition中国研究中心 8 个：Beijing、Changsha、Chongqing、Guangzhou、Nanjing、Qingdao 等 8 地
- 招募中NCT07319832A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome中国研究中心 4 个：Guangzhou、Hangzhou、Shanghai
- 招募中NCT07704047A Clinical Study of FT1 in Patients With Short Bowel Syndrome中国研究中心 1 个：Nanjing
其他状态的试验（9 项）
- 已完成NCT01974336The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome Patients中国研究中心 1 个：Nanjing
- 状态未知NCT02452177Preventive and Reversional Effect of Vitamin D on Parenteral Nutrition Associated Liver Disease中国研究中心 1 个：Nanjing
- 已完成NCT02699320Intestinal Microbial Dysbiosis in Chinese Infants With Short Bowel Syndrome With Different Complications中国研究中心 1 个：Shanghai
- 状态未知NCT03590418Microbial Diversity of Small Bowel Stoma Effluent and Colonic Faeces中国研究中心 1 个：Shanghai
- 状态未知NCT06427642Efficacy Evaluation of UCB-MNCs in the Treatment of Refractory Neonatal Diseases中国研究中心 1 个：Jinan
- 已完成NCT06523101A Study of PJ009 in Healthy Adult Volunteers中国研究中心 1 个：Taiyuan
- 已完成NCT07186608Specific Dietary Fibers May Enhance Colonic Adaptation in Short Bowel Syndrome Through Microbial and Metabolic Mechanisms That Drive Functional Compensation.中国研究中心 1 个：Nanjing
- 进行中·不再招募NCT06973304A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome中国研究中心 4 个：Changping、Dongcheng、Nanjing、Siming
- 已完成NCT07297238Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.中国研究中心 2 个：Nanjing、Nanning
中国境外的在招试验 24L2
这些试验在中国没有研究中心，通常无法直接报名——入组一般要求在当地居住并接受随访。列在这里是因为它另有用处：看清楚全世界正在试哪些药、做到了哪一期、由谁在做。把药名和 NCT 编号记下来去问主治医生，或据此进一步查该药是否已在境外获批、是否有拓展性用药（expanded access）通道。
美国10法国5比利时4丹麦4德国4意大利4波兰3英国3澳大利亚2奥地利2加拿大2匈牙利2荷兰2韩国2另有 13 个国家/地区
CT.gov 报告命中 24 项，此处取回并展示最近的 15 项。
- 招募中NCT07742735A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)阿根廷、澳大利亚、奥地利、比利时、巴西、加拿大、捷克、丹麦 等 22 国
- 招募中NCT07392801AGE Accumulation in Patients on Long-term Parenteral Nutrition法国
- 招募中NCT07703371Kodo Millet Porridge and Its Effects on Gut Health and Metabolic Syndrome印度
- 尚未开始招募NCT07530055Role of the Microbiota in Intestinal Adaptation During Short Bowel Syndrome
- 招募中NCT07197944Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS奥地利、比利时、丹麦、芬兰、法国、德国、匈牙利、意大利 等 14 国
- 尚未开始招募NCT07206004Effect of Parenteral Support on FibroScan in Short Bowel Syndrome丹麦
- 招募中NCT07713641Short-Chain Fatty Acids in Lypopolysaccharide-Induced Inflammation and Executive Function比利时
- 招募中NCT07714499Resting Energy Expenditure by Gastrointestinal Functional Status斯洛文尼亚
- 招募中NCT06904872Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)德国、意大利
- 招募中NCT06877923Elemental 028 Extra Case Studies英国
- 招募中NCT06771505SBS DISK- Creation of a Quality of Life Tool for Short Bowel Patients Compared With a Validated Quality of Life Questionnaire (SBS QoL)法国
- 招募中NCT06668922Irritable Bowel Syndrome and Control Volunteers: Diet Challenge美国
- 招募中NCT07400783TED_ORG: Study on Short Bowel Syndrome意大利
- 招募中NCT05535361A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome美国
- 招募中NCT05432648Fiber Food Introduction in Pediatric Short Bowel Syndrome美国
外部标识与链接
发现这一页有错误？告诉我 · 邮件主题会自动带上本页的 ORPHA 编号
本页数据来源
- 疾病定义、同义词、基因、表型、流行病学：Orphanet（CC BY 4.0）
- 中文病名：Orphanet 中文包，冻结于 2020-06-01
- 表型中文标签：HPO 简体中文翻译（CHPO 上游成果）